Preparation of the cardiac patient for noncardiac surgery

Keyphrases

• Alpha Agonist 66%
• Beta-blockers 66%
• Cardiac Patients 100%
• Clinical High Risk 66%
• Diagnostic Evaluation 33%
• Dosing Regimen 33%
• Exercise Capacity 66%
• Exercise Tolerance 33%
• High Risk 100%
• High-risk Surgery 33%
• Ischemia 33%
• Left Ventricular Dysfunction 33%
• Medical Therapy 33%
• Moderate Risk 33%
• Myocardial Ischemia 33%
• Noncardiac Surgery 100%
• Optimal Dosing 33%
• Optimal Timing 33%
• Patient Characteristics 33%
• Risk Factors 33%
• Specific Risk 33%
• Statins 66%
• Stress Testing 66%
• Subclinical Coronary Artery Disease 33%
• Vascular Surgery 33%
• Ventricular Function 33%

Medicine and Dentistry

• Alpha-Adrenergic Agonist 100%
• Beta Adrenergic Receptor Blocking Agent 100%
• Cardiovascular System 50%
• Combination Therapy 50%
• Coronary Artery Disease 50%
• Diagnosis 50%
• Drug Therapy 50%
• Exercise 100%
• Exercise Tolerance 50%
• Heart Left Ventricle Failure 50%
• Heart Muscle Ischemia 50%
• Heart Ventricle Function 50%
• Ischemia 50%
• Noncardiac Surgery 100%
• Statin 100%
• Surgical Risk 50%
• Vascular Surgery 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha Adrenergic Receptor Stimulating Agent 100%
• Beta Adrenergic Receptor Blocking Agent 100%
• Combination Therapy 50%
• Coronary Artery Disease 50%
• Heart Left Ventricle Failure 50%
• Heart Muscle Ischemia 50%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 100%
• Ischemia 50%